arrow_back Back to App

Securing Gene Synthesis: New Rules for Genetic Materials

This act introduces new rules for the production and sale of synthetic genetic materials to reduce the risk of misuse. Companies producing these materials will need to implement special screening protocols, and government agencies will only be able to purchase them from verified suppliers. The goal is to enhance safety in biotechnology.
Key points
Companies producing synthetic genetic materials (DNA/RNA) must implement mandatory screening protocols to detect potential misuse of their products.
Federal agencies and entities receiving federal funds will only be able to purchase synthetic genetic materials from suppliers verified for compliance with new safety rules.
In case of violations, entities may lose federal research funding, ensuring adherence to the new regulations.
The act defines synthetic genetic materials, gene synthesis equipment, and gene synthesis providers to facilitate the application of the new rules.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4702
Sponsor: Rep. Eshoo, Anna G. [D-CA-16]
Process start date: 2023-07-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Securing Gene Synthesis Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_4702.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-07-18.

What are the main provisions?

Key points include:

  • Companies producing synthetic genetic materials (DNA/RNA) must implement mandatory screening protocols to detect potential misuse of their products.
  • Federal agencies and entities receiving federal funds will only be able to purchase synthetic genetic materials from suppliers verified for compliance with new safety rules.
  • In case of violations, entities may lose federal research funding, ensuring adherence to the new regulations.
  • The act defines synthetic genetic materials, gene synthesis equipment, and gene synthesis providers to facilitate the application of the new rules.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Eshoo, Anna G. [D-CA-16].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Security